The University of Michigan CVC team has extensive experience in treating patients with atrial fibrillation (Afib), an abnormal type of heart rhythm, for conditions that range from simple to complex. Treatment plans are tailored to each patient’s individual needs, with the goal of helping patients realize an improved quality of life.
Joann Drayton credits Dr. Hakan Oral with helping her get back to the stage.
Sixty-five-year-old Joann Drayton was accustomed to the spotlight for much of her life. An established opera singer and a choreographer for full-scale productions at Jackson Community College, she was active and involved in the things she loved to do. But when diagnosed with Afib some 15 years ago, Joann’s health began to deteriorate to the point where she felt she just couldn’t function anymore. All that changed when she was introduced to Dr. Hakan Oral, who helped her rediscover the spotlight.
Joann shares her story …
“Dr. Oral is a brilliant doctor who gave me my life back. I suffered from Afib and atrial flutter and also had a history of stroke — conditions that I began experiencing around age 50. Through the years, I was put on as many as eight medications, which eventually left me unable to do the things I loved doing. It was difficult for me to walk up the stairs, let alone perform on stage and manage choreography for the theater group at Jackson Community College. Continue reading →
September is National Atrial Fibrillation Awareness Month
Atrial fibrillation (“a-tree-uhl fih-bruh-lay-shun”), or A-fib, is an irregular heart rhythm (arrhythmia) that starts in the upper portion (atria) of the heart. A-fib affects more than 5 million Americans and is the most common arrhythmia that leads to hospitalization. A-fib is the leading cause of stroke and is associated with an increase in morbidity and mortality. During A-fib, the upper chambers of the heart beat rapidly and erratically in a chaotic way without any effective muscle contraction. A-fib may develop as a result of changes in the heart due to age. Hypertension (high blood pressure), valvular heart disease, coronary artery disease, over-activity of the thyroid gland or excessive alcohol intake may promote A-fib. There can also be a genetic component. Continue reading →
Anticoagulants like Coumadin or Jantoven are prescribed to prevent the formation of blood clots.
If you’re taking warfarin, also known as Coumadin® or Jantoven®, your doctor has prescribed this anticoagulation medication to prevent the formation of harmful blood clots or to treat an existing blood clot. Atrial fibrillation (A-fib) is a common condition for taking warfarin because the risk of stroke is higher in A-fib patients.
The American Heart Association reports that more than two million Americans have atrial fibrillation, a rhythmic disorder of the heart where the atria (the heart’s pumping chambers) quiver instead of beat. As a result, some blood remains in the heart instead of being pumped out, allowing pools to collect in the heart chamber, where clots may form. These clots can travel to the brain, causing a stroke.
Atrial fibrillation (a-tree-uhl fih-bruh-lay-shun), or “afib” (ay-fib), is an irregular heart rhythm (arrhythmia) that starts in the upper parts (atria) of the heart. A common type of arrhythmia in those over the age of 60, “atrial fibrillation is being diagnosed with increasing prevalence,” says Michele Derheim, director of clinical operations at the University of Michigan Frankel Cardiovascular Center and a registered nurse. “The quicker you’re treated for an afib condition, the better your chances are for good cardiovascular health.”
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.